Teva Branded Pharmaceutical Products R&d Llc

This early-stage trial tested a new drug called modakafusp alfa (TAK-573) combined with standard myeloma treatments in 15 adults with multiple myeloma. The main goal was to check safety and find the best dose. The study was terminated early, so we have limited information on how …

This study tested a new drug, modakafusp alfa, combined with daratumumab for people with multiple myeloma that had returned or stopped responding to treatment. The main goals were to check safety and find the best dose. Only 15 people took part before the study was stopped early.

This study tested an experimental drug called modakafusp alfa in people with multiple myeloma that had returned or stopped responding to at least three prior treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The trial was stopped early, but the…

This study tested a new drug called modakafusp alfa, alone or with pembrolizumab, in 45 adults with advanced solid tumors or melanoma that couldn't be removed by surgery. The main goals were to check safety and find the best dose. The study was terminated early, so results are li…